T Cell News and Research

Latest T Cell News and Research

Study sheds light on how human gut microbes break down processed foods

A new study from Washington University School of Medicine in St. Louis sheds light on how human gut microbes break down processed foods - especially potentially harmful chemical changes often produced during modern food manufacturing processes.

9 Oct 2019

β-blockers could regenerate infant heart muscle, mitigate effects of congenital heart disease

Surgery can mend congenital heart defects shortly after birth, but those babies will carry a higher risk of heart failure throughout the rest of their lives. Yet, according to a Science Translational Medicine study published today by UPMC Children's Hospital of Pittsburgh researchers, β-blockers could supplement surgery to regenerate infant heart muscle and mitigate the lasting effects of congenital heart disease.

9 Oct 2019

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

As tumor cells multiply, they often spawn tens of thousands of genetic mutations. Figuring out which ones are the most promising to target with immunotherapy is like finding a few needles in a haystack.

9 Oct 2019

Initial use of ART alters host environment to allow formation of long-lived HIV reservoir

Antiretroviral therapy (ART) can suppress HIV to the point where the virus is nearly undetectable, and people on medication can live many years. But therapy cannot completely eradicate the virus; it persists in reservoirs inside immune cells, a phenomenon called "latency."

9 Oct 2019

Army scientists develop new weapon to combat super-bugs

Antibiotic resistance is a one of the world's most pressing public health problems. Army scientists have developed a new weapon to combat super-bugs, which could protect Soldiers and fight resistance.

9 Oct 2019

Cell discovery could help fight against liver disease

Scientists have identified new sub-types of cells that, when they interact, accelerate the scarring process in diseased livers.

9 Oct 2019

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

An Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the "dark matter" of human cancer DNA.

9 Oct 2019

More sensitive electrophysiology tools needed to study cancer cell populations

Bioelectricity of Cancer, a special issue of the peer-reviewed journal Bioelectricity, has just been published. Two promising discoveries are well delineated: an ultra-sensitive tool to detect cancer and a new therapeutic target for cancer immunotherapy.

9 Oct 2019

Cell death 'blocker' could speed recovery and save lives

Scientists in Australia have shown that they can successfully stop the process of cell death (apoptosis) through a revolutionary new compound.

9 Oct 2019

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.

9 Oct 2019

DeNovix granted Japanese patent for CellDrop Automated Cell Counter

DeNovix Inc. announces the award of Japanese PatentNo. 6579475 covering their innovation in the field of cell counting.

From DeNovix Inc. 9 Oct 2019

Unique immune cell linked to remission in patients with triple negative breast cancer

A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College London.

From The Francis Crick Institute 9 Oct 2019

Lab-grown, testosterone-producing cells could help treat hypogonadism

Researchers have managed to grow human, testosterone-producing cells, which could lead to improved treatment options for low testosterone levels.

9 Oct 2019

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primary cancer.

8 Oct 2019

X-ray crystallography can provide inaccurate information about protein structure

A new study by chemists at the University of Arkansas shows that X-ray crystallography, the standard method for determining the structure of proteins, can provide inaccurate information about a critical set of proteins - those found in cell membranes - which in turn could be leading to poor and inefficient drug design.

8 Oct 2019

Combination treatment cures pancreatic cancer, reprograms the immune system

A University of Rochester Wilmot Cancer Institute research team reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram the immune system to create an "immune memory" in the same way that a vaccine keeps the flu away.

8 Oct 2019

Biology and computers meld to help understand how breast cancer develops

Among the most deadly killers in the area of cancer, breast cancer is also extremely difficult to treat, once it has spread to the bones. Not only does it metastasize rapidly, but it comprises a variety of cell types and also depends on the input from many other non-breast cells during the initiation, growth and spread of the cancer. This complexity makes it more difficult to develop targeted therapies in this condition.

8 Oct 2019

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

Patients with advanced melanoma have been able to live longer because of several newly approved targeted treatment options, including BRAF and MEK inhibitors. However, patients will often have different responses to the same treatment due to genetic variability.

8 Oct 2019

New understanding of breast cancer metastasis to bone

In breast cancer patients with metastatic disease, bone is the most common site of metastasis and the most common site of first distant relapse, with roughly half (48%) of breast cancer patients developing bone metastases after treatment.

8 Oct 2019

New grants support research on mechanics of tumor cells

At the cellular level, cancer can be viewed as a mechanical engineering challenge. The disease alters the structure and function of cells and tissues, which are meant to perform very specific tasks.

8 Oct 2019

T Cell News and Research

Latest T Cell News and Research

Study sheds light on how human gut microbes break down processed foods

β-blockers could regenerate infant heart muscle, mitigate effects of congenital heart disease

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

Initial use of ART alters host environment to allow formation of long-lived HIV reservoir

Army scientists develop new weapon to combat super-bugs

Cell discovery could help fight against liver disease

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

More sensitive electrophysiology tools needed to study cancer cell populations

Cell death 'blocker' could speed recovery and save lives

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

DeNovix granted Japanese patent for CellDrop Automated Cell Counter

Unique immune cell linked to remission in patients with triple negative breast cancer

Lab-grown, testosterone-producing cells could help treat hypogonadism

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

X-ray crystallography can provide inaccurate information about protein structure

Combination treatment cures pancreatic cancer, reprograms the immune system

Biology and computers meld to help understand how breast cancer develops

Differences at the single-cell level can predict responses to BRAF inhibitor therapy

New understanding of breast cancer metastasis to bone

New grants support research on mechanics of tumor cells

Immunology eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in